State of New Jersey Common Pension Fund D Raises Holdings in Ventas, Inc. $VTR

State of New Jersey Common Pension Fund D increased its holdings in Ventas, Inc. (NYSE:VTR) by 2.3% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 395,692 shares of the real estate investment trust’s stock after acquiring an additional 9,006 shares during the period. State of New Jersey Common Pension Fund D owned approximately 0.08% of Ventas worth $30,619,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in VTR. BI Asset Management Fondsmaeglerselskab A S raised its position in Ventas by 97.7% in the third quarter. BI Asset Management Fondsmaeglerselskab A S now owns 36,713 shares of the real estate investment trust’s stock worth $2,570,000 after acquiring an additional 18,146 shares in the last quarter. Schroder Investment Management Group raised its position in Ventas by 3.6% in the third quarter. Schroder Investment Management Group now owns 2,487,572 shares of the real estate investment trust’s stock worth $170,946,000 after acquiring an additional 85,340 shares in the last quarter. Vanguard Group Inc. raised its position in Ventas by 2.5% in the third quarter. Vanguard Group Inc. now owns 73,598,827 shares of the real estate investment trust’s stock worth $5,151,182,000 after acquiring an additional 1,802,515 shares in the last quarter. Aberdeen Group plc raised its position in Ventas by 8.3% in the third quarter. Aberdeen Group plc now owns 1,580,923 shares of the real estate investment trust’s stock worth $109,985,000 after acquiring an additional 120,825 shares in the last quarter. Finally, Krilogy Financial LLC purchased a new position in Ventas in the third quarter worth $919,000. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

VTR has been the subject of several research analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and issued a $93.00 price objective on shares of Ventas in a research report on Monday, February 9th. Scotiabank raised their price target on Ventas from $80.00 to $93.00 and gave the company a “sector perform” rating in a research report on Monday, March 2nd. Royal Bank Of Canada raised their price target on Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a research report on Tuesday, February 10th. Mizuho raised their price target on Ventas from $87.00 to $94.00 and gave the company an “outperform” rating in a research report on Wednesday, March 4th. Finally, Morgan Stanley set a $90.00 price target on Ventas in a research report on Friday, February 13th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $91.47.

Insider Transactions at Ventas

In related news, CEO Debra A. Cafaro sold 10,322 shares of Ventas stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $77.66, for a total transaction of $801,606.52. Following the completion of the sale, the chief executive officer owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. This trade represents a 0.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares of the company’s stock, valued at approximately $6,184,175. This represents a 32.81% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.53% of the company’s stock.

Ventas Trading Up 0.7%

Shares of VTR stock opened at $87.99 on Friday. Ventas, Inc. has a fifty-two week low of $61.76 and a fifty-two week high of $88.41. The stock has a market cap of $41.84 billion, a P/E ratio of 159.98, a P/E/G ratio of 2.15 and a beta of 0.75. The business has a fifty day simple moving average of $84.79 and a 200-day simple moving average of $80.03. The company has a quick ratio of 0.67, a current ratio of 0.25 and a debt-to-equity ratio of 0.95.

Ventas (NYSE:VTR) last announced its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the business earned $0.84 EPS. The company’s quarterly revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, analysts forecast that Ventas, Inc. will post 3.85 earnings per share for the current fiscal year.

Ventas Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, April 16th. Investors of record on Tuesday, March 31st were given a dividend of $0.52 per share. The ex-dividend date was Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. This is a boost from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio (DPR) is 378.18%.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.